Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1920 ARTÍCULOS , VIENDO DEL 1846 AL 1860

Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects

Tong B, Ba Y, Li Z, Yang C, Su K, Qi H, Zhang D, Liu X, Wu Y, Chen Y, Ling J, Zhang J, Yin X, Yu P.

Neurobiol Dis. 2024 Jun 15;196:106505. doi: 10.1016/j.nbd.2024.106505. Epub 2024 Apr 19.

Silent Information Regulator 1/Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α Axis: A Promising Target for Parkinson's and Alzheimer's Disease Therapies

Goyal A, Kumari A, Verma A, Chaudhary V, Agrawal V, Yadav HN.

J Biochem Mol Toxicol. 2024 Dec;38(12):e70078. doi: 10.1002/jbt.70078.

Luteolin: Nature's promising warrior against Alzheimer's and Parkinson's disease

Goyal A, Solanki K, Verma A.

J Biochem Mol Toxicol. 2024 Jan;38(1):e23619. doi: 10.1002/jbt.23619. Epub 2023 Dec 13.

Immunotherapy for Parkinson's Disease and Alzheimer's Disease: A Promising Disease-Modifying Therapy

Mahboob A, Ali H, AlNaimi A, Yousef M, Rob M, Al-Muhannadi NA, Senevirathne DKL, Chaari A.

Cells. 2024 Sep 12;13(18):1527. doi: 10.3390/cells13181527.

Does gut brain axis has an impact on Parkinson's disease (PD)?

Elangovan A, Dahiya B, Kirola L, Iyer M, Jeeth P, Maharaj S, Kumari N, Lakhanpal V, Michel TM, Rao KRSS, Cho SG, Yadav MK, Gopalakrishnan AV, Kadhirvel S, Kumar NS, Vellingiri B.

Ageing Res Rev. 2024 Feb;94:102171. doi: 10.1016/j.arr.2023.102171. Epub 2023 Dec 21.

Nanotechnology-based Drug Delivery for Alzheimer's and Parkinson's Diseases

Nguyen-Thi PT, Ho TT, Nguyen TT, Vo GV.

Curr Drug Deliv. 2024;21(7):917-931. doi: 10.2174/1567201820666230707113405.

Communal interaction of glycation and gut microbes in diabetes mellitus, Alzheimer's disease, and Parkinson's disease pathogenesis

Patil RS, Tupe RS.

Med Res Rev. 2024 Jan;44(1):365-405. doi: 10.1002/med.21987. Epub 2023 Aug 17.

Potential implications of polyphenolic compounds in neurodegenerative diseases

Shi R, Gao D, Stoika R, Liu K, Sik A, Jin M.

Crit Rev Food Sci Nutr. 2024;64(16):5491-5514. doi: 10.1080/10408398.2022.2155106. Epub 2022 Dec 16.

The molecular interplay between human and bacterial amyloids: Implications in neurodegenerative diseases

Jain N.

Biochim Biophys Acta Proteins Proteom. 2024 Jul 1;1872(4):141018. doi: 10.1016/j.bbapap.2024.141018. Epub 2024 Apr 17.

Apolipoprotein E Gene in α-Synucleinopathies: A Narrative Review

Liampas I, Kyriakoulopoulou P, Siokas V, Tsiamaki E, Stamati P, Kefalopoulou Z, Chroni E, Dardiotis E.

Int J Mol Sci. 2024 Feb 1;25(3):1795. doi: 10.3390/ijms25031795.

Upstream lipid and metabolic systems are potential causes of Alzheimer's disease, Parkinson's disease and dementias

Cooper O, Hallett P, Isacson O.

FEBS J. 2024 Feb;291(4):632-645. doi: 10.1111/febs.16638. Epub 2022 Oct 12.

How do HCN channels play a part in Alzheimer's and Parkinson's disease?

Zhang Z, Luo X, Jiang L, Wu H, Tan Z.

Ageing Res Rev. 2024 Sep;100:102436. doi: 10.1016/j.arr.2024.102436. Epub 2024 Jul 22.

Infiltration of immune cells to the brain and its relation to the pathogenesis of Alzheimer's and Parkinson's diseases

Netzahualcoyotzi C, Santillán-Cigales JJ, Adalid-Peralta LV, Velasco I.

J Neurochem. 2024 Sep;168(9):2316-2334. doi: 10.1111/jnc.16106. Epub 2024 Mar 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias